Arcus Biosciences Inc (RCUS)
15.94
+0.24
(+1.53%)
USD |
NYSE |
May 06, 13:21
Arcus Biosciences Market Cap: 1.448B for May 6, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| May 03, 2024 | 1.427B |
| May 02, 2024 | 1.408B |
| May 01, 2024 | 1.408B |
| April 30, 2024 | 1.384B |
| April 29, 2024 | 1.420B |
| April 26, 2024 | 1.413B |
| April 25, 2024 | 1.338B |
| April 24, 2024 | 1.402B |
| April 23, 2024 | 1.408B |
| April 22, 2024 | 1.334B |
| April 19, 2024 | 1.326B |
| April 18, 2024 | 1.348B |
| April 17, 2024 | 1.348B |
| April 16, 2024 | 1.442B |
| April 15, 2024 | 1.480B |
| April 12, 2024 | 1.507B |
| April 11, 2024 | 1.571B |
| April 10, 2024 | 1.520B |
| April 09, 2024 | 1.586B |
| April 08, 2024 | 1.542B |
| April 05, 2024 | 1.576B |
| April 04, 2024 | 1.569B |
| April 03, 2024 | 1.607B |
| April 02, 2024 | 1.610B |
| April 01, 2024 | 1.679B |
| Date | Value |
|---|---|
| March 28, 2024 | 1.716B |
| March 27, 2024 | 1.655B |
| March 26, 2024 | 1.513B |
| March 25, 2024 | 1.497B |
| March 22, 2024 | 1.493B |
| March 21, 2024 | 1.567B |
| March 20, 2024 | 1.589B |
| March 19, 2024 | 1.572B |
| March 18, 2024 | 1.565B |
| March 15, 2024 | 1.725B |
| March 14, 2024 | 1.665B |
| March 13, 2024 | 1.731B |
| March 12, 2024 | 1.694B |
| March 11, 2024 | 1.727B |
| March 08, 2024 | 1.635B |
| March 07, 2024 | 1.628B |
| March 06, 2024 | 1.759B |
| March 05, 2024 | 1.706B |
| March 04, 2024 | 1.727B |
| March 01, 2024 | 1.736B |
| February 29, 2024 | 1.738B |
| February 28, 2024 | 1.740B |
| February 27, 2024 | 1.834B |
| February 26, 2024 | 1.786B |
| February 23, 2024 | 1.775B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
295.27M
Minimum
Aug 23 2019
3.405B
Maximum
Nov 23 2021
1.539B
Average
1.501B
Median
Market Cap Benchmarks
| Gilead Sciences Inc | 80.80B |
| Catalyst Pharmaceuticals Inc | 1.748B |
| Integra Lifesciences Holdings Corp | 1.800B |
| Vertex Pharmaceuticals Inc | 104.21B |
| Adverum Biotechnologies Inc | 213.59M |
Market Cap Related Metrics
| PS Ratio | 10.08 |
| PEG Ratio | -0.3323 |
| Price to Book Value | 3.135 |
| Price | 15.94 |
| Earnings Yield | -26.04% |
| PEGY Ratio | -0.3323 |